Objective:To establish a method for determination of two derivatives of cyanide in biomaterials by headspace gas chromatography mass spectrometry.Methods:In February 2024, blood and urine samples were placed in headspace sampling vials. Phosphoric acid, or phosphoric acid and chloramine T solution, was added respectively to derivatize cyanide into hydrogen cyanide or cyanogen chloride. After equilibrating at 80°C for 15 minutes, headspace sampling was performed. The samples were separated by a GS-GasPro chromatographic column and determined by gas chromatography-mass spectrometry in selected ion monitoring (SIM) mode. Qualitative analysis was conducted using both retention time and the ratio of characteristic ions, and quantitative analysis was carried out by the external standard method.Results:The correlation coefficients (r) for the two derivatives was 0.9992 and 0.9984, respectively. The detection limits was 0.10 μg/ml and 0.05 μg/ml, respectively. The recoveries ranged from 73.7% to 98.4%, with precision (RSD) ranging from 3.3% to 14.2%.Conclusion:The method offers the advantages of simple operation, precise quantification, high qualitative reliability, and high sensitivity, making it suitable for cyanide detection in biological materials.

Objective:To establish a method for determination of two derivatives of cyanide in biomaterials by headspace gas chromatography mass spectrometry.Methods:In February 2024, blood and urine samples were placed in headspace sampling vials. Phosphoric acid, or phosphoric acid and chloramine T solution, was added respectively to derivatize cyanide into hydrogen cyanide or cyanogen chloride. After equilibrating at 80°C for 15 minutes, headspace sampling was performed. The samples were separated by a GS-GasPro chromatographic column and determined by gas chromatography-mass spectrometry in selected ion monitoring (SIM) mode. Qualitative analysis was conducted using both retention time and the ratio of characteristic ions, and quantitative analysis was carried out by the external standard method.Results:The correlation coefficients (r) for the two derivatives was 0.9992 and 0.9984, respectively. The detection limits was 0.10 μg/ml and 0.05 μg/ml, respectively. The recoveries ranged from 73.7% to 98.4%, with precision (RSD) ranging from 3.3% to 14.2%.Conclusion:The method offers the advantages of simple operation, precise quantification, high qualitative reliability, and high sensitivity, making it suitable for cyanide detection in biological materials.

OBJECTIVE To explore the action mechanism of kushenol F （KSCF） in treating ulcerative colitis （UC） in mice. METHODS The potential targets of KSCF intervening in UC were predicted with network pharmacology and molecular docking. C57BL/6J mice were randomly divided by body weight into model group， positive control group （sulfasalazine， 703 mg/kg）， KSCF group （100 mg/kg）， and normal group， with 6 mice per group. The UC model of mice was induced by dextran sulfate sodium solution. During the modeling period， the mice were given relevant medicine intragastrically， once a day， for 7 consecutive days. After the last administration， the disease activity index （DAI） of the mice was scored； the length of the mice’s colon was measured； pathological changes in the colon tissue of mice were observed； the levels of lipopolysaccharide （LPS） in serum， myeloperoxidase （MPO）， nitric oxide （NO） and superoxide dismutase （SOD） in the colon were detected in mice； the expression levels of occludin and ZO-1 in colon tissue of mice were detected； the proportions of CD3+T， CD4+T， and CD8+T lymphocytes in the spleen and the ratio of CD4+/CD8+ were detected； changes in colonic microbiota were analyzed by 16S rDNA sequencing. RESULTS Results of network pharmacology indicated that KSCF may treat UC by regulating signaling pathways such as phosphatidylinositol-3 kinase/protein kinase B （PI3K/AKT） and nuclear factor kappa B （NF- κB）. Molecular docking results showed that KSCF bound most stably with NF-κB p65 protein. Animal experiment results demonstrated that， compared with the model group， the pathological characteristics of colon tissue in mice were improved in KSCF group. DAI scores， serum levels of LPS， the levels of MPO，NF-κB p65 phosphorylation and NLRP3 protein expression in the colon， and the proportion of CD8+T lymphocytes in the spleen were reduced significantly （P＜0.05）. Body weight， SOD levels， expression levels of occludin and ZO-1 in the colon， proportions of CD3+T and CD4+T lymphocytes， and the CD4+/CD8+ ratio in the spleen were significantly increased （P＜0.05）； the abundance of Firmicutes， Actinobacteria， Akkermansia， and Lactobacillus genera were increased， while Proteobacteria decreased； the microbial community structure tended towards that of the normal group. CONCLUSIONS KSCF alleviates UC by restoring intestinal microbial imbalance， enhancing immune response， and inhibiting colonic inflammatory responses， thereby improving intestinal barrier integrity.